O

Oxford BioTherapeutics

45 employees

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Protein Target Discovery
Antibody-Drug Conjugates
Proteomics
Immune-Oncology
Therapeutics
Cancer
Health Diagnostics
Genetics
Health Care
Oncology

Date founded

2004

Funding rounds raised

Total raised

$10M

from 11 investors over 11 rounds

O

Oxford BioTherapeutics raised undisclosed on November 19, 2018

Investors: Renaissance Capital Partners

O

Oxford BioTherapeutics raised undisclosed on July 29, 2018

Investors: Renaissance Capital Partners

O

Oxford BioTherapeutics raised $10M on January 26, 2017

Investors: Oxford Finance LLC

O

Oxford BioTherapeutics raised $1.1M on August 20, 2010

Investors: South East Growth Fund and -

O

Oxford BioTherapeutics raised $1.1M on March 23, 2010

Investors: South East Growth Fund

O

Oxford BioTherapeutics raised $1.2M on February 24, 2009

Investors: South East Growth Fund and -

O

Oxford BioTherapeutics raised $1.3M on August 15, 2008

Investors: -

O

Oxford BioTherapeutics raised $3.9M on January 4, 2007

Investors: South East Growth Fund and -

FAQ